Cite
Kozlova A, Thabault L, Dauguet N, et al. Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase. Eur J Med Chem. 2021;227:113892doi: 10.1016/j.ejmech.2021.113892.
Kozlova, A., Thabault, L., Dauguet, N., Deskeuvre, M., Stroobant, V., Pilotte, L., Liberelle, M., Van den Eynde, B., & Frédérick, R. (2022). Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase. European journal of medicinal chemistry, 227113892. https://doi.org/10.1016/j.ejmech.2021.113892
Kozlova, Arina, et al. "Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase." European journal of medicinal chemistry vol. 227 (2022): 113892. doi: https://doi.org/10.1016/j.ejmech.2021.113892
Kozlova A, Thabault L, Dauguet N, Deskeuvre M, Stroobant V, Pilotte L, Liberelle M, Van den Eynde B, Frédérick R. Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase. Eur J Med Chem. 2022 Jan 05;227:113892. doi: 10.1016/j.ejmech.2021.113892. Epub 2021 Oct 07. PMID: 34678572.
Copy
Download .nbib